Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease

Figure 11

The proposed mechanism by which SFN inhibits urease synthesis by H. pylori and, in so doing, reduces the disease risks associated with H. pylori infection (an image adapted from Fahey et al. [220]).